Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Open-Label Continuation Study of the Long-term Safety and Efficacy of Adalimumab (D2E7) in Japanese Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00647400 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00647400
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00647400 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Open-Label Continuation Study of the Long-term Safety and Efficacy of Adalimumab (D2E7) in Japanese Subjects With Moderate to Severe Chronic Plaque Psoriasis
Lead sponsor
Abbott
Phase
Phase 2/3
Overall status
Completed
Start date
April 30, 2006
Completion date
April 30, 2010
Enrollment
147 (actual)
Sites
64

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis